Cargando…

Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM

BACKGROUND: Dapagliflozin is a sodium–glucose co transporter-2 inhibitor that proved efficacy in reduction of blood glucose level through extrusion of glucose in urine. It is used in treatment of type 2 diabetes mellitus (T2DM). It also has reported cardiovascular and renal benefits in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nada, Aml Mohamed, Younan, Mariam Adel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970182/ https://www.ncbi.nlm.nih.gov/pubmed/33796252 http://dx.doi.org/10.1177/2042018821995364

Ejemplares similares

Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
por: Mussa, Bashair M, et al.
Publicado: (2021)

A 5-structured visits multidisciplinary clinical care approach to optimize the care of patients with type 2 diabetes: a pilot study
por: Allam, Magdy Mohamed, et al.
Publicado: (2023)

Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study
por: Al Bataineh, Mohammad Tahseen, et al.
Publicado: (2020)

Inflammatory markers and cardiovascular risks among overweight-obese Emirati women
por: Alkaabi, Juma, et al.
Publicado: (2016)

Publisher Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study
por: Al Bataineh, Mohammad Tahseen, et al.
Publicado: (2021)

Author Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study
por: Al Bataineh, Mohammad Tahseen, et al.
Publicado: (2021)

Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
por: Xue, LiMing, et al.
Publicado: (2021)

Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Prevalence, Causes, and Risk Factors of Visual Impairment in Emiratis and Non-Emiratis of Dubai: A Subnational Population-Based Cross-Sectional Survey
por: Taryam, Manal O., et al.
Publicado: (2022)

Risk factors for vitamin D deficiency in Abu Dhabi Emirati population
por: Al Zarooni, Amal Abdul Rahim, et al.
Publicado: (2022)

Clinical and biochemical characteristics of familial type 1 diabetes mellitus (FT1DM) compared to non-familial type 1 DM (NFT1DM)
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Cholecalciferol improves glycemic control in type 2 diabetic patients: a 6-month prospective interventional study
por: Nada, Aml Mohamed, et al.
Publicado: (2017)

A 1000 Arab genome project to study the Emirati population
por: Al-Ali, Mariam, et al.
Publicado: (2018)

Red cell distribution width in type 2 diabetic patients
por: Nada, Aml Mohamed
Publicado: (2015)

Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
por: Avgerinos, Ioannis, et al.
Publicado: (2019)

Effect of Dapagliflozin on Exercise Capacity and Cardiovascular Risk in Patients with Heart Failure
por: Nazer, Rakan, et al.
Publicado: (2022)

Impact of Dapagliflozin on the Left Ventricular Diastolic Function in Diabetic Patients with Heart Failure Complicating Cardiovascular Risk Factors
por: Soga, Fumitaka, et al.
Publicado: (2021)

Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
por: Sonesson, Christian, et al.
Publicado: (2016)

Emirati Adolescents’ and Young Adults’ Usage of Social Media for Health Information
por: Barqawi, Hiba Jawdat, et al.
Publicado: (2023)

Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China
por: Yao, Younan, et al.
Publicado: (2020)

Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women
por: Elbiss, Hassan M., et al.
Publicado: (2015)

Effect of Dapagliflozin on Clinical Outcome after Drug-Eluting Stent Implantation in Elderly T2DM Patients: A Real-World Study
por: Lin, Yuan, et al.
Publicado: (2023)

Quality of Life of Emirati Women with Breast Cancer
por: Smail, Linda, et al.
Publicado: (2022)

Diet Quality Indices in Relation to Cardiovascular Risk Factors in T2DM Patients: A Systematic Review
por: Sepandi, Mojtaba, et al.
Publicado: (2022)

Factors affecting the motivation of healthcare professionals providing care to Emiratis with type 2 diabetes
por: Alhyas, Layla, et al.
Publicado: (2013)

Cephalometric characterization of an adult Emirati sample with Class I malocclusion
por: Al Zain, Tayseer, et al.
Publicado: (2012)

VKORC1 variants as significant predictors of warfarin dose in Emiratis
por: Al-Mahayri, Zeina N, et al.
Publicado: (2019)

Dietary Patterns and Their Associations With the FTO and FGF21 Gene Variants Among Emirati Adults
por: Naja, Farah, et al.
Publicado: (2021)

Maternal investment, life-history trajectory of the off-spring and cardiovascular disease risk in Emirati females in the United Arab Emirates
por: Al Ghali, Rola, et al.
Publicado: (2021)

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients
por: Ghuman, Nasrullah K, et al.
Publicado: (2015)

Secondary association of PDLIM5 with paranoid schizophrenia in Emirati patients
por: Moselhy, Hamdy, et al.
Publicado: (2015)

Oxidative damage and associated inflammatory risk factors in obese Emirati women: Body mass index versus waist circumference
por: Gariballa, Salah, et al.
Publicado: (2017)

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus
por: Saleem, Fatima
Publicado: (2017)

Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway
por: Yue, Zhaodi, et al.
Publicado: (2021)

Phenotypic Spectrum of STXBP1 Gene Mutations in an Emirati Case Series
por: Pawar, Nikhil, et al.
Publicado: (2023)

The prevalence, risk factors, and screening measure for prediabetes and diabetes among Emirati overweight/obese children and adolescents
por: Al Amiri, Elham, et al.
Publicado: (2015)

Oxidative Damage and Inflammation in Obese Diabetic Emirati Subjects
por: Gariballa, Salah, et al.
Publicado: (2014)

Menopause-Specific Quality of Life among Emirati Women
por: Smail, Linda, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l5s73sf93g1hrha8tb0en542pb